Research programme: dimeric IgA antibody therapeutics - TigaTx
Latest Information Update: 04 Feb 2025
Price :
$50 *
At a glance
- Originator TigaTx
- Class Anti-infectives; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Neutrophil stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Infections